Bio Break: Surprising Innovations in Olfactory Drug Delivery
In this episode of Bio Break, Joris van der Heijden and Nick Allan explore one of the most innovative approaches in drug delivery: olfactory drug delivery. This cutting-edge method targets the olfactory region of the nose, offering a direct pathway to deliver drugs into the brain while bypassing the blood-brain barrier. Unlike traditional intranasal delivery, this highly specialized technique uses neural pathways to achieve precise and effective results.
Nick shares insights from a fascinating project that leverages the olfactory bulb and cribriform plate—a thin, porous structure within the skull—to transport therapeutic agents directly to the brain. These pathways allow drugs to reach the brain without systemic circulation, overcoming the challenges of the blood-brain barrier that typically blocks most substances.
The discussion also delves into the complexity of nasal anatomy, highlighting the natural defenses that prevent substances from entering the brain. Structures like the nasal valve and turbinates serve critical roles in filtering air and protecting the body, but they also pose significant challenges for targeted drug delivery. Through precise engineering and careful design, the device Nick describes achieves a delicate balance of usability and effectiveness, allowing for safe and accurate drug delivery to the olfactory region.
This approach is especially promising for conditions like Alzheimer’s, Parkinson’s, brain tumors, and other neurological diseases that require direct access to the brain for treatment. By bypassing traditional barriers, olfactory drug delivery opens new opportunities for targeted therapies that were previously inaccessible.
This episode is a must-watch for medical device developers, pharmaceutical innovators, and healthcare professionals interested in the latest advancements in drug delivery technology. Gain insights into how precision engineering and biological understanding can come together to solve complex challenges and unlock groundbreaking treatments for patients.
Surprising Innovations in Olfactory Drug Delivery
Related Resources
We all know medical devices have labels, but how often do we consider their purpose and the effort required to ensure they provide the right information? Device labelling serves as the interface between the manufacturer, the user, and regulatory bodies. (Note that being from Canada, we spell labelling with two Ls.)
Sterilization is a critical process in the medical device industry as it provides a reliable way to ensure that devices are free from harmful microorganisms when they are used on patients. This blog talks about the categories of sterilization currently used on medical devices in manufacturing settings. It also addresses concerns surrounding the use of ethylene oxide (EtO), an indispensable method for sterilizing heat and moisture sensitive devices.
Predicting the trends of a new year is always interesting and a bit unpredictable. We asked our medical device design and development professionals to submit their most interesting medtech trends for 2025 and the reasoning behind their prediction. The results were surprisingly focused on two major trends: Home Healthcare and Wearable Devices. Within these categories, several technologies were identified including edge computing, IoT, and connected devices. In no particular ranking, here are our 2025 predictions:
The U.S. Food and Drug Administration (FDA) and the Office for Human Research Protections (OHRP) have released a draft guidance document, Considerations for Including Tissue Biopsies in Clinical Trials, issued in January 2025. It provides recommendations for sponsors, investigators, institutions, and Institutional Review Boards (IRBs) on the safe and ethical incorporation of tissue biopsies in clinical trials.